Form 4: Recursion Pharmaceuticals CFO Ben R. Taylor Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Ben R. Taylor, CFO of Recursion Pharmaceuticals, disposed of 10,879 shares to cover tax obligations related to restricted stock units on February 18, 2025.
Summary
- On February 18, 2025, Ben R. Taylor, the Chief Financial Officer of Recursion Pharmaceuticals, disposed of 10,879 shares of Class A Common Stock.
- The disposal was to cover tax withholding and remittance obligations related to the net settlement of restricted stock units.
- The price per share for the transaction was $10.64.
- Following the transaction, Taylor directly owns 875,727 shares of Class A Common Stock.
- Taylor also holds multiple stock options with varying exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions for tax purposes. It doesn't convey any particularly positive or negative sentiment about the company's performance or outlook.
Industry Context
This filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the company's overall prospects or strategy.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 11/17/2021 | 25% of shares subject to $0.04 stock option award vest and become exercisable. |
| 04/03/2022 | 25% of shares subject to $0.06 stock option award vest and become exercisable. |
| 07/01/2022 | 25% of shares subject to $0.14 stock option award vest and become exercisable. |
| 01/02/2025 | 1/48th of shares subject to $6.09 stock option award vests and becomes exercisable. |
| 02/18/2025 | Date of stock disposal for tax obligations. |
| 03/01/2025 | 1/48th of shares subject to $7.25 stock option award vests and becomes exercisable. |
| 11/26/2030 | Expiration date for stock options with an exercise price of $0.04. |
| 04/02/2031 | Expiration date for stock options with an exercise price of $0.06. |
| 07/01/2031 | Expiration date for stock options with an exercise price of $0.14. |
| 12/18/2034 | Expiration date for stock options with an exercise price of $6.09. |
| 02/03/2035 | Expiration date for stock options with an exercise price of $7.25. |
Keywords
Form 4, Beneficial Ownership, RXRX, Recursion Pharmaceuticals, Ben R. Taylor, CFO, Stock Disposal, Tax Withholding, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.